Intelligent Bio Solutions Inc. (INBS)

USD 1.27

(0.79%)

Operating Income Summary of Intelligent Bio Solutions Inc.

  • Intelligent Bio Solutions Inc.'s latest annual operating income in 2024 was -10.28 Million USD , up 18.36% from previous year.
  • Intelligent Bio Solutions Inc.'s latest quarterly operating income in 2024 FY was -10.28 Million USD , up 18.36% from previous quarter.
  • Intelligent Bio Solutions Inc. reported an annual operating income of -12.59 Million USD in 2023, down -51.08% from previous year.
  • Intelligent Bio Solutions Inc. reported an annual operating income of -8.33 Million USD in 2022, down -49.58% from previous year.
  • Intelligent Bio Solutions Inc. reported a quarterly operating income of -2.52 Million USD for 2024 Q1, up 6.52% from previous quarter.
  • Intelligent Bio Solutions Inc. reported a quarterly operating income of -1.99 Million USD for 2024 Q2, up 21.18% from previous quarter.

Annual Operating Income Chart of Intelligent Bio Solutions Inc. (2024 - 2017)

Historical Annual Operating Income of Intelligent Bio Solutions Inc. (2024 - 2017)

Year Operating Income Operating Income Growth
2024 -10.28 Million USD 18.36%
2023 -12.59 Million USD -51.08%
2022 -8.33 Million USD -49.58%
2021 -5.57 Million USD -105.97%
2020 -2.7 Million USD 59.79%
2019 -6.72 Million USD -46.18%
2018 -4.6 Million USD -2560.96%
2017 -173 Thousand USD 0.0%

Peer Operating Income Comparison of Intelligent Bio Solutions Inc.

Name Operating Income Operating Income Difference
Aspira Women's Health Inc. -18.85 Million USD 45.453%
bioAffinity Technologies, Inc. -7.97 Million USD -28.971%
Standard BioTools Inc. -76.6 Million USD 86.575%
Inotiv, Inc. -81.46 Million USD 87.376%
Prenetics Global Limited -52.51 Million USD 80.418%
Neuronetics, Inc. -30.55 Million USD 66.344%
Star Equity Holdings, Inc. -4.34 Million USD -136.612%
Castle Biosciences, Inc. -67.97 Million USD 84.873%
Psychemedics Corporation -2.92 Million USD -252.043%
RadNet, Inc. 98.69 Million USD 110.419%
Exact Sciences Corporation -215.01 Million USD 95.217%
IDEXX Laboratories, Inc. 1.09 Billion USD 100.937%
iSpecimen Inc. -11.16 Million USD 7.934%
OpGen, Inc. -15.68 Million USD 34.454%
Exagen Inc. -22.83 Million USD 54.971%
Bionano Genomics, Inc. -215.24 Million USD 95.223%
CareDx, Inc -101.9 Million USD 89.909%
Check-Cap Ltd. -19.28 Million USD 46.683%
Twist Bioscience Corporation -220.83 Million USD 95.343%
Guardant Health, Inc. -564.72 Million USD 98.179%
Biodesix, Inc. -41.34 Million USD 75.127%
BioNexus Gene Lab Corp. -2.59 Million USD -296.484%
Precipio, Inc. -7.62 Million USD -34.95%
Natera, Inc. -446.24 Million USD 97.696%
Fulgent Genetics, Inc. -72.69 Million USD 85.854%
Sera Prognostics, Inc. -39.82 Million USD 74.177%
23andMe Holding Co. -321.35 Million USD 96.8%
OPKO Health, Inc. -157.02 Million USD 93.451%
Personalis, Inc. -109.93 Million USD 90.646%
Aclaris Therapeutics, Inc. -97.35 Million USD 89.438%
Applied DNA Sciences, Inc. -10.95 Million USD 6.118%
T2 Biosystems, Inc. -49.66 Million USD 79.295%
Neogen Corporation 58.66 Million USD 117.529%
Myriad Genetics, Inc. -123.7 Million USD 91.687%
ICON Public Limited Company 956.15 Million USD 101.075%
NeoGenomics, Inc. -107.73 Million USD 90.455%
Star Equity Holdings, Inc. -4.34 Million USD -136.612%
MDxHealth SA -27.32 Million USD 62.37%
Prenetics Global Limited -52.51 Million USD 80.418%
Illumina, Inc. -1.06 Billion USD 99.038%
DarioHealth Corp. -56.18 Million USD 81.699%
ENDRA Life Sciences Inc. -10.52 Million USD 2.258%
Medpace Holdings, Inc. 336.82 Million USD 103.053%
Mainz Biomed B.V. -26.64 Million USD 61.406%
Trinity Biotech plc -27.04 Million USD 61.978%
Sotera Health Company 276.69 Million USD 103.716%
bioAffinity Technologies, Inc. -7.97 Million USD -28.971%